Research and Development

 

Viscogel AB develops a novel medical chitosan – Viscosan^® – and viscoelastic gel – ViscoGel^® – with unique properties and utility in the development of improved vaccines, drug delivery systems and emulsions. The products are based on Viscogel AB’s proprietary technology.

 

The EU has provided funding to the ViVac project which has the objective of showing clinical Proof-of-Concept for ViscoGel^® as an adjuvant.